Nos Publications
Retrouvez tous nos travaux de Recherche2019
Vialaret J, Lehmann S, Hirtz C. |
Lepleux C, Marie-Brasset A, Temelie M, Boulanger M, Brotin E, Goldring MB, Hirtz C, Varès G, Nakajima T, Saintigny Y, Savu D, Chevalier F. |
Relaño-Ginés A, Lehmann S, Deville de Périère D, Hirtz C. |
Peyron PA, Lehmann S, Delaby C, Baccino E, Hirtz C. |
Paterson RW, Gabelle A, Lucey BP, Barthélemy NR, Leckey CA, Hirtz C, Lehmann S, Sato C, Patterson BW, West T, Yarasheski K, Rohrer JD, Wildburger NC, Schott JM, Karch CM, Wray S, Miller TM, Elbert DL, Zetterberg H, Fox NC, Bateman RJ. |
Murall CL, Rahmoun M, Selinger C, Baldellou M, Bernat C, Bonneau M, Boué V, Buisson M, Christophe G, D’Auria G, Taroni F, Foulongne V, Froissart R, Graf C, Grasset S, Groc S, Hirtz C, Jaussent A, Lajoie J, Lorcy F, Picot E, Picot MC, Ravel J, Reynes J, Rousset T, Seddiki A, Teirlinck M, Tribout V, Tuaillon É, Waterboer T, Jacobs N, Bravo IG, Segondy M, Boulle N, Alizon S. |
Pontier D, Picart C, El Baidouri M, Roudier F, Xu T, Lahmy S, Llauro C, Azevedo J, Laudié M, Attina A, Hirtz C, Carpentier MC, Shen L, Lagrange T. |
Contreras-Aguilar MD, Vialaret J, de Périère DD, Escribano D, Lehmann S, Tecles F, Cerón JJ, Hirtz C. |
Thouvenot E, Demattei C, Lehmann S, Maceski-Maleska A, Hirtz C, Juntas-Morales R, Pageot N, Esselin F, Alphandéry S, Vincent T, Camu W. |
2018
Vialaret J, Wessels H, van Gool AJ, Lehmann S, Gabelle A, Wood J, Bern M, Paape R, Suckau D, Kruppa G and C Hirtz. Journal of Proteomics (IF :3.88). 2018 Mar 20;175:12-26, https://www.ncbi.nlm.nih.gov/pubmed/28855124 Towards a routine application of Top-Down approaches for Label-Free discovery Workflows. |
Mertens B, Orti V, Vialaret J, Gibert P, Relaño-Ginés A, Lehmann S, de Périère DD, Hirtz C. Bioanalysis. 2018 Jan;10(1):35-45. doi: 10.4155/bio-2017-0218 (IF:2.7), https://www.ncbi.nlm.nih.gov/pubmed/29243487 Assessing a multiplex-targeted proteomics approach for the clinical diagnosis of periodontitis using saliva samples. |
Dauvilliers Y, Chenini S, Vialaret J, Delaby C, Guiraud L, Gabelle A, Lopez R, Hirtz C, Jaussent I, Lehmann S. Mov Disord. 2018 Feb 8. doi: 10.1002/mds.27287, https://www.ncbi.nlm.nih.gov/pubmed/29418021 Association between serum hepcidin level and restless legs syndrome. |
Vialaret J, Picas A, Delaby C, Bros P, Lehmann S, Hirtz C. Journal of Chromatography B. 2018, Vol 1086: 110-117, https://www.ncbi.nlm.nih.gov/pubmed/29660664 Nano-flow vs standard-flow: Which is the more suitable LC/MS method for quantifying hepcidin-25 in human serum in routine clinical settings? |
Orti V, Mertens B, Vialaret J, Gibert P, Relaño-Ginés A, Lehmann S, de Périère DD, Hirtz C. Data in Brief. 2018, Vol 18, Pages 294-299, https://www.ncbi.nlm.nih.gov/pubmed/29900194 Data from a targeted proteomics approach to discover biomarkers in saliva for the clinical diagnosis of periodontitis. |
Vialaret J, Wessels H, van Gool AJ, Lehmann S, Gabelle A, Wood J, Bern M, Paape R, Suckau D, Kruppa G and Hirtz C. Data in Brief. 2018, Vol 18, June 2018, Pages 1013-1021, https://www.ncbi.nlm.nih.gov/pubmed/29900270 Identification of multiple proteoforms biomarkers on clinical samples by routine Top-Down approaches. |
Vialaret J, Kadi S, Tiers L, O’Flynn R, Lehmann S and Hirtz C. Current Topics in Peptide & Protein Research, 2018 Sous presse, https://www.researchgate.net/publication/331015018 Albumin depletion of human serum to improve quantitative clinical proteomics”. |
Fortea J, Carmona-Iragui M, Benejam B, Fernández S, Videla L, Barroeta I, Alcolea D, Pegueroles J, Muñoz L, Belbin O, de Leon MJ, Maceski AM, Hirtz C, Clarimón J, Videla S, Delaby C, Lehmann S, Blesa R, Lleó A. Lancet Neurol. 2018 : 17(10):860-869, https://www.ncbi.nlm.nih.gov/pubmed/30172624 Plasma and CSF biomarkers for the diagnosis of Alzheimer’s disease in adults with Down syndrome: a cross-sectional study. |
Piton M, Hirtz C, Desmetz C, Milhau J, Lajoix AD, Bennys K, Lehmann S, Gabelle A. J Alzheimers Dis. 2018;65(1):3-13, https://www.ncbi.nlm.nih.gov/pubmed/30040716 Alzheimer’s Disease: Advances in Drug Development. |
Vialaret J, Broutin S, Pugnier C, Santelé S, Jaffuel A, Barnes A, Tiers L, Pelletier L, Lehmann S, Paci A, Hirtz C. Bioanalysis. 2018 May 1;10(10):723-735, https://www.ncbi.nlm.nih.gov/pubmed/29771137 What sample preparation should be chosen for targeted MS monoclonal antibody quantification in human serum? |
Incamps A, Saez-Boiteau C, Tiede SL, Rebillard P, Schulte J, Vialaret J, Beinrucker A, Lehmann S, Hirtz C. Bioanalysis. 2018 Sep 1;10(17):1383-1399, https://www.ncbi.nlm.nih.gov/pubmed/30207162 Impact of biological matrix on inflammatory protein biomarker quantification based on targeted mass spectrometry. |
Darlix A, Hirtz C, Thezenas S, Maceski A, Gabelle A, Lopez-Crapez E, De Forges H, Firmin N, Guiu S, Jacot W, Lehmann S. BMC Cancer. 2019 Jan 30;19(1):110, https://bmccancer.biomedcentral.com/articles/10.1186/s12885-019-5287-z The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases. |
Molinari N, Roche S, Peoc’h K, Tiers L, Séveno M, Hirtz C, Lehmann S. Front Mol Neurosci. 2018 Dec 18;11:477, https://www.ncbi.nlm.nih.gov/pubmed/30618622 Sample Pooling and Inflammation Linked to the False Selection of Biomarkers for Neurodegenerative Diseases in Top-Down Proteomics: A Pilot Study. |
2017
Maleska A, Hirtz C, Casteleyn E, Villard O, Ducos J, Avignon A, Sultan A, Lehmann S. Bioanalysis. 2017 Mar;9(5):427-434 (IF:2.7), https://www.ncbi.nlm.nih.gov/pubmed/28220711 Comparison of HbA1c detection in whole blood and dried blood spots using an automated ion-exchange HPLC system. |
Lasocki S, Puy H, Mercier G, Lehmann S, Asfar P, Mercat A, Gaillard T, Gergaud S, Lasocki S, Sargentini C, Geneve C, Montravers P, Lefebvre T, Puy H, Mercier G, Nagot N, Delaby C, Hirtz C, Lehmann S, Vialaret J, Chanques G, Jaber S, Asehnoune K, Roquilly A, Dahyot-Fizelier C, Mimoz O, Isslame S, Seguin P, Barbaz M, Ferrandiere M. Anaesth Crit Care Pain Med. 2017 Sep 14. pii: S2352-5568(17)30089-9. doi: 10.1016 (IF:1.54), https://www.ncbi.nlm.nih.gov/pubmed/28919067 Impact of iron deficiency diagnosis using hepcidin mass spectrometry dosage methods on hospital stay and costs after a prolonged ICU stay: Study protocol for a multicentre, randomised, single-blinded medico-economic trial. |
Quijada‐Morin N, Garcia F, Lambert K, Walker A‐S, Tiers L, Viaud M, Sauvage F‐X, Hirtz C and Saucier C. Australian Journal of Grape and Wine Research. (2017) doi: 10.1111/ajgw.12322 (IF:2.635), https://www.researchgate.net/publication/321754809 Strain effect on extracellular laccase activities from Botrytis cinereal. |
2016
Hirtz C, Vialaret J, Nowak N, Gabelle A, Deville de Périère D and Lehmann S |
Hirtz C, Vialaret J, Gabelle A, Nowak N, Dauvilliers Y and Lehmann S. |
Lehmann S, Vialaret J, Delatour V, Bros P, Brede C, Hirtz C and on behalf of the IFCC Working Group on Clinical Quantitative Mass Spectrometry Proteomics (WG-cMSP). |
Hassan D, Provansal M, Lehmann S, Rizk M, Moez P, Vialaret J, Hirtz C, Essa A, Agamia H. |
Renard D, Gabelle A, Hirtz C, Demattei C, Thouvenot E and Lehmann S. |
2015
Tall ML, Lehmann S, Diouf E, Gérard C, Filali S, Hirtz C, Gabert L, Sauvinet V, Pirot F, Pivot C. |
Hirtz C, Lehmann S. |
Bros P, Vialaret J, Barthelemy N, Delatour V, Gabelle A, Lehmann S, Hirtz C. |
Morzel M, Neyraud E, Brignot H, Ducoroy P, Jeannin A, Lucchi G, Truntzer C, Canlet C, Tremblay-Franco M, Hirtz C, Gaillard S, Peretti N, Feron G. |
Bros P, Delatour V, Vialaret J, Lalere B, Barthelemy N, Gabelle A, Lehmann S, Hirtz C. |
Lehmann S, Vialaret J, Gras Combe G, Bauchet L, Hanon O, Girard M, Gabelle A, Hirtz C. |
Renard D, Waconge A, Ayrignac X, Mahmoud C, Fourcade G, Azakri S, Le Floch A, Bouly S, Marelli C, Tosi C, Arquizan C, Hirtz C, Gabelle A, Thouvenot E and Lehmann S. |
Lehmann S and Hirtz C. |
Bissonnette L, Antoine Y, Tiers L, Hirtz C, Lehmann S, Bissonnette F, Kadoch I.J, Haouzi D, Hamama S. |
Barthélemy N, Fenaille F, Hirtz C, Sergeant N, Schraen-Maschke S, Vialaret J, Buée L, Gabelle A, Junot C, Lehmann S and Becher F. |
Hirtz C, Vialaret J, Nouadje G, Schraen S, Benlian P, Mary S, Philibert P, Tiers L, Bros P, Delaby C, Gabelle A, Lehmann S. |
2014
Delaby C, Gabelle A, Meynier P, Loubiere V, Vialaret J, Tiers L, Ducos J, Hirtz C and Lehmann S. Clin Chem Lab Med (2014). 23:1-7. (IF : 3), https://www.ncbi.nlm.nih.gov/pubmed/24150208 Development and validation of dried matrix spot sampling for the quantitative determination of amyloid beta peptides in cerebrospinal fluid. |
Lehmann S, Schraen S, Quadrio I, Paquet C, Bombois S, Delaby C, Dorey A, Dumurgier J, Hirtz C, Krolak-Salmon P, Laplanche JL, Moreaud O, Peoc’h K, Rouaud O, Sablonnière B, Thouvenot E, Touchon J, Vercruysse O, Hugon J, Gabelle A, Pasquier F, Perret-Liaudet A. Alzheimers Dement (2014). S1552-5260(13)02495-3. (IF : 14.5), https://www.ncbi.nlm.nih.gov/pubmed/24269268 Impact of harmonization of collection tubes on Alzheimer’s disease diagnosis. |
Delaby C, Vialaret J, Bros P, Gabelle A, Lefebvre T, Puy H, Hirtz C and Lehmann S. |
Lehmann S, Vialaret J, Seveno M, Tiers L, Gabelle A and Hirtz C. Journal of Proteomics & Bioinformatics (2014). (IF : 2.6), http://dx.doi.org/10.4172/jpb.S5-003 Comparison of hydrophobic, lipophilic and immunodepletion pre-fractionation methods for label-free LC-MS/MS identification of biomarkers in human cerebrospinal fluid. |
Barthelemy N, Lehmann S, Hirtz C, Gabelle A, Sergeant N, Fenaille F, Vialaret J, Schraen S, Bros P, Tiers L, Delaby C, Junot C, Touchon J, Buee L, Becher F. Alzheimer’s & Dementia (2014). 10 (no. 4 sup): p. 147. (IF : 14.5), https://www.researchgate.net/publication/266895833 Detection and Quantification of the Tau Protein and Its Isoforms in the CSF of Alzheimer’s Disease Patients Using Mass Spectrometry. |
2013
Lehmann S, Hoofnagle A, Hochstrasser D, Brede C, Glueckmann M, Cocho JA, Ceglarek U, Lenz C, Vialaret J, Scherl A, Hirtz C. |
Lehmann S, Delaby C, Vialaret J, Ducos J, Hirtz C. Clin Chem Lab Med (2013). 1:1-13. (IF : 3), https://www.researchgate.net/publication/237060490 Current and future use of « dried blood spot » analyses in clinical chemistry. |
Lehmann S, Delaby C, Touchon J, Hirtz C and Gabelle A. Rev. Neurol (2013). 1 6 9. 7 1 9 – 7 2 3. (IF : 0.6), https://www.ncbi.nlm.nih.gov/pubmed/24021316 Biomarkers of Alzheimer’s disease: the present and the future. |
2011
Lehmann S, Poinot P, Tiers L, Junot C, Becher F, Hirtz C. |

Plateforme de Protéomique Clinique
Institute for Regenerative Medicine & Biotherapy (IRMB)
Hôpital Saint Eloi
80 rue Augustin Fliche
34295 MONTPELLIER – Cedex 5
FRANCE